Sharemaestro Newsreel

AQR Capital discloses 4.99% Haemonetics Corp (HAE) position in Schedule 13G/A

AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 4.99% in Haemonetics Corp (HAE) common stock. This position, totaling 2,266,489 shares, was reported in a Schedule 13G/A filing as of June 30, 2026. The entities …

BrainsWay Releases Q2 2026 Financial Results

BrainsWay Ltd. (BWAY) reported Q2 2026 financial results, meeting profit expectations with diluted EPS of $0.07 and beating revenue estimates with $17.1M. The company's Deep TMS technology drove a 35% revenue surge year-over-year, shipping 125 systems in the quarter, and set full-year revenue guidance …

The Abbott Big Ten $1 Million Blood Drive is Back

The Abbott Big Ten $1 Million Blood Drive returns for its third year, with Nebraska aiming to reclaim the title from Wisconsin. The competition, which runs from August 26th to December 4th, encourages donations to help address a national blood crisis, with a $1 …

PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 4.8% - What's Next?

PROCEPT BioRobotics (NASDAQ:PRCT) shares fell 4.8% after reporting mixed Q2 2026 results with revenue growth but a larger-than-expected loss and continued unprofitability. The company faces a class-action lawsuit regarding alleged misleading statements about demand and inventory, adding to investor uncertainty. Despite a CEO stock …

Owlet, Inc. 2026 Q2 - Results - Earnings Call Presentation (NYSE:OWLT) 2026-08-12

[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Whey Protein Market size & share revenue was valued at approximately USD 12.58 Billion in 2024 and is expected to reach …

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …

MaxCyte, Inc. (MXCT) Reports Q2 Loss, Beats Revenue Estimates

MaxCyte, Inc. (MXCT) reported a Q2 loss of $0.08 per share, exceeding the Zacks Consensus Estimate of a $0.12 loss, and surpassed revenue estimates with $7.27 million. Despite beating earnings and revenue expectations in some recent quarters, the stock has underperformed the market this …

Glaukos Corp stock hits all-time high at 184.45 USD

Glaukos Corp (GKOS) stock has reached an all-time high of $184.45, reflecting a 100.01% increase over the past year and a 41.55% revenue surge in Q2 2026. Despite an InvestingPro analysis suggesting the stock may be overvalued, 11 analysts have revised earnings upwards, indicating …

IceCure Medical Ltd Q2 2026 Earnings Call Summary

IceCure Medical Ltd Q2 2026 Earnings Call Summary - Moby Strategic Performance and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …

CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric Push

CeriBell is expanding its brainwave-monitoring platform beyond seizure detection, introducing new products for delirium and pediatric patients, and eventually stroke. The company's technology offers faster, more accessible EEG monitoring in acute care settings, supported by AI-powered detection algorithms. CeriBell aims to grow its hospital …

MOBI - Stroke Recovery Focus And Expanding Stroke Center Programs Will Drive Long Term Opportunity

Mobia Medical (MOBI) is positioned for long-term growth due to its Vivistim Paired VNS therapy for stroke recovery, targeting a large and underserved patient population. Analysts project significant revenue growth of 50.3% annually over the next three years, expecting the company to reach profitability …

Bank of America (OM) reports 3.5% beneficial stake in Outset Medical shares

Bank of America Corporation has reported a beneficial ownership of 3.5% in Outset Medical, Inc., holding 666,596 shares of common stock. This stake, representing a shared voting and dispositive power, is held through several of its wholly-owned subsidiaries. The filing indicates that Bank of …

AQR Capital discloses 6.44% Inspire Medical Systems (INSP) ownership on Schedule 13G

AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 6.44% in Inspire Medical Systems, Inc. (INSP) through a Schedule 13G filing. The AQR entities collectively own 1,856,800 shares, with shared voting power over 1,783,224 shares …

Orthofix (OFIX) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief IR and Communications Officer - Julie Dewey President and Chief Executive Officer - Massimo Calafiore Chief Financial Officer - Julie Andrews Full Conference Call Transcript Operator: Thank …

Nano-X Imaging (NASDAQ: NNOX) Optimizes Nanox.AI Medical Imaging Framework for Intel Core Ultra Processors

Nano-X Imaging Ltd. announced that its subsidiary, Nanox.AI Ltd., has optimized its medical imaging AI application framework for Intel Core Ultra processors using the Intel OpenVINO toolkit. This optimization allows healthcare facilities to deploy CT imaging AI applications on on-premise edge devices, keeping imaging …

GE HealthCare (GEHC) Upgraded to Buy: Here's What You Should Know

GE HealthCare (GEHC) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates. This upgrade suggests an improvement in the company's underlying business and could lead to a favorable impact on its stock price. The Zacks Rank …

Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?

Ceribell Wins FDA Nod for AI Tools on Its Neurology Portal

Ceribell has received FDA 510(k) clearances for two AI enhancements integrated into its cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction. These tools aim to improve the diagnosis of epilepsy and streamline the interpretation of EEGs by automatically highlighting abnormal brain wave patterns …

Here's Why You Should Add BrightSpring Stock to Your Portfolio Now

BrightSpring Health Services, Inc. BTSG is well-poised for growth in the coming quarters, backed by strong momentum in Provider Services, expanding specialty and infusion operations, successful integration of acquired home health assets and a scalable home-based care platform. However, the Inflation Reduction Act (IRA)-related …

CVRx chief revenue officer exits amid slowing sales and execution concerns

CVRx Inc. has announced the departure of its chief revenue officer following a reduction in its full-year revenue guidance. The company attributes the lowered outlook to employee turnover and productivity issues, which have impacted sales of its primary product, Barostim, a device for heart …

PBH or SYK: Which Is the Better Value Stock Right Now?

Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own …

Insulet (PODD) Could Be 39% Undervalued After Strong Earnings And Higher 2026 Outlook

NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up

NeuroPace (NPCE) reported strong second-quarter 2026 results, with earnings and revenues surpassing Zacks Consensus Estimates, driven by significant growth in its RNS System. The company also raised its full-year 2026 revenue guidance and improved its adjusted EBITDA loss outlook. NeuroPace highlighted advancements in AI-based …

Medtronic veteran departs for CEO role at heart valve startup

Bill Shields, a long-time Medtronic executive specializing in transcatheter mitral and tricuspid therapies, has been appointed CEO of Versa Vascular. Versa Vascular is a startup developing a minimally invasive transcatheter device called AdapTR to treat tricuspid valve regurgitation. Shields' appointment comes as Versa Vascular …

BofA Securities Maintains Beta Bionics(BBNX.US) With Hold Rating, Raises Target Price to $18

BofA Securities has maintained its Hold rating on Beta Bionics (BBNX.US) and increased its target price for the company's stock to $18. This adjustment reflects BofA's updated outlook for Beta Bionics.

LivaNova (LIVN) Q2 2026 Earnings Call Transcript

LivaNova reported record Q2 2026 revenue of $390.6 million and adjusted diluted EPS of $1.26, exceeding prior-year figures, driven by strong demand in Cardiopulmonary and Epilepsy segments. The company raised its full-year 2026 revenue guidance to 8%-9% growth and adjusted diluted EPS guidance to …

Earnings call transcript: IceCure Medical misses Q2 2026 estimates as shares fall

IceCure Medical reported a 45% year-over-year revenue increase to $1.8 million for the first half of 2026, driven by higher ProSense system sales and disposable probe utilization. The company's U.S. commercial install base grew by 70% to over 30 sites following FDA clearance for …

Mobia Medical (NASDAQ:MOBI) Price Target Raised to $17.00

JPMorgan Chase & Co. has increased its price target for Mobia Medical (NASDAQ:MOBI) to $17.00 from $15.00, maintaining an "overweight" rating and suggesting a 35.24% upside. Despite the company's revenue more than doubling year-over-year to $13.51 million, it reported a larger-than-expected loss of $1.10 …

What Abbott Laboratories (ABT)'s AI-Powered Google Health Partnership Means For Shareholders

Abbott Laboratories has partnered with Google Health to integrate glucose insights from its Lingo biowearable into the Google Health app, using AI for personalized metabolic health coaching and unified wellness data. This collaboration includes a large-scale metabolic health study, potentially supporting Abbott's diabetes franchise …

Zimmer Biomet (ZBH): Capital International Investors reports 6.4% ownership stake

Capital International Investors has reported a 6.4% ownership stake in Zimmer Biomet Holdings, Inc. (ZBH), totaling 12,438,366 shares. This passive investment grants them sole voting power over 12,279,364 shares and sole dispositive power over all 12,438,366 shares, as detailed in a Schedule 13G SEC …

908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference

908 Devices Inc. announced that its CEO and CFO will present at the 17th Annual Midwest IDEAS Conference on August 26, 2026. The company, which specializes in handheld chemical analysis tools, will host investor meetings and webcast its presentation. This event provides an opportunity …

ITOC, PTHL UPCOMING DEADLINE: Levi & Korsinsky Alerts iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) Stockholders of Securities Class Action - Contact the Firm

Levi & Korsinsky, LLP has filed a securities class action lawsuit against iTonic Holdings Ltd (f/k/a Pheton Holdings Ltd) (NASDAQ: ITOC, PTHL) on behalf of shareholders who purchased securities between September 5, 2024, and July 29, 2025. The lawsuit alleges that iTonic warned generically …

AdaptHealth Corp. (AHCO) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky, LLP has issued a securities investigation notice for AdaptHealth Corp. (AHCO) after the company reported second-quarter 2026 revenue and earnings significantly below analyst expectations. Shares of AdaptHealth fell as much as 26% following the announcement of a $0.99 GAAP loss per …

AdaptHealth misses Q2 revenue and earnings estimates, shares drop 26%.

AdaptHealth Corp. (AHCO) reported a significant miss on Q2 2026 revenue and earnings estimates, with revenue at $740.3 million against an anticipated $847 million, and a GAAP loss of $0.99 per share compared to an expected loss of $0.15. This poor performance led to …

Smith & Nephew (SNN): executive share awards vest, partial sale to cover tax

Smith & Nephew plc reported that performance share awards granted in 2023 to Rohit Kashyap, President of Advanced Wound Management and Global Commercial Operations, vested on August 12, 2026. Of the 23,202 ordinary shares that vested, 9,163 were sold to cover tax liabilities, with …